Literature DB >> 2864646

Effects of ketamine on the dynorphin levels and the ethylketocyclazocine (EKC) receptor binding in discrete regions of rat brains.

K Pongdhana, N Ogawa, Y Hirose, S Ohara, F Kosaka, S Tachibana.   

Abstract

Intraperitoneal (ip) injection of ketamine increased the concentration of dynorphin in the cortex of rat brain, while decreased it in the septal area. The affinity of ethylketocyclazocine (EKC) receptor binding was decreased in the cortex, but increased in the septal area after pretreating the rats with ketamine. This suggests that the dynorphin neuronal system is stimulated in the cortex and suppressed in the septal area by ketamine. In other 5 brain areas, ketamine had no effect on neither dynorphin concentration nor EKC receptor binding. As dynorphin was reported to produce seizure and spike discharge in the cortex while suppressed the hippocampal EEG of rat brain, it is likely that the dynorphin neuronal system may play at least a part in ketamine induced electrophysiological changes in the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864646     DOI: 10.1007/bf00964631

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

Authors:  E F DOMINO; P CHODOFF; G CORSSEN
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

2.  Properties of soluble somatostatin-binding protein.

Authors:  N Ogawa; T Thompson; H G Friesen; J B Martin; P Brazeau
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

3.  The EEG, evoked potentials, and single-unit activity during ketamine anesthesia in cats.

Authors:  Y Kayama; K Iwama
Journal:  Anesthesiology       Date:  1972-04       Impact factor: 7.892

4.  Dynorphin (1-17): lack of analgesia but evidence for non-opiate electrophysiological and motor effects.

Authors:  J M Walker; H C Moises; D H Coy; E A Young; S J Watson; H Akil
Journal:  Life Sci       Date:  1982 Oct 18-25       Impact factor: 5.037

5.  Multiple forms of immunoreactive dynorphin in human pituitary and pheochromocytoma.

Authors:  T Suda; F Tozawa; S Tachibana; H Demura; K Shizume; A Sasaki; T Mouri; Y Miura
Journal:  Life Sci       Date:  1983-02-21       Impact factor: 5.037

6.  Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.

Authors:  K Yoshimura; J P Huidobro-Toro; N M Lee; H H Löh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

7.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

Authors:  C Chavkin; I F James; A Goldstein
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

8.  The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine.

Authors:  Gary M Pekoe; David J Smith
Journal:  Pain       Date:  1982-01       Impact factor: 6.961

9.  The interaction of ketamine with the opiate receptor.

Authors:  D J Smith; G M Pekoe; L L Martin; B Coalgate
Journal:  Life Sci       Date:  1980-03-10       Impact factor: 5.037

10.  Opiate receptor mediation of ketamine analgesia.

Authors:  A D Finck; S H Ngai
Journal:  Anesthesiology       Date:  1982-04       Impact factor: 7.892

View more
  1 in total

1.  Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain.

Authors:  K Pongdhana; N Ogawa; Y Hirose; T Ono; F Kosaka; A Mori
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.